Advanced Medical Solutions Group Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0004536594
GBP
2.08
-0.01 (-0.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Advanced Medical Solutions Group Plc stock-summary
stock-summary
Advanced Medical Solutions Group Plc
Pharmaceuticals & Biotechnology
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.
Company Coordinates stock-summary
Company Details
Premier Park, 33 Road One , WINSFORD None : CW7 3RT
stock-summary
Tel: 44 1606 863500
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Peter Allen
Non-Executive Chairman of the Board
Mr. Andrew Meredith
Group Chief Executive Officer, Executive Director
Mr. Eddie Johnson
Chief Financial Officer, Executive Director, Company Secretary
Mr. Stephen Bellamy
Non-Executive Independent Director
Ms. Penelope Freer
Senior Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 455 Million (Small Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.28%

stock-summary
Debt Equity

0.21

stock-summary
Return on Equity

5.36%

stock-summary
Price to Book

1.78